---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-035959"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2026-05-18T20:30:33+00:00"
generated_at: "2026-05-18T20:32:22.238334+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Medtronic neuroscience president Brett Wall to depart; Kweli Thompson named successor

## Summary
- Brett Wall steps down as EVP & President, Neuroscience Portfolio; effective June 1, 2026.
- Dr. Kweli Thompson moves from SVP & President, Cardiac Rhythm Management to succeed him.
- Wall will remain an employee through September 1, 2026 to assist transition.
- Severance consistent with Medtronic's executive severance practices per 2025 proxy.

## SEC filing metadata
- accession: 0001628280-26-035959
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2026-05-18T20:30:33+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/0001628280-26-035959-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/mdt-20260518.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-035959
- JSON: https://secwatch.observer/filing/0001628280-26-035959.json
- Plain text: https://secwatch.observer/filing/0001628280-26-035959.txt

## Key facts
- Executive change
  Brett Wall departed as Executive Vice President and President, Neuroscience Portfolio at Medtronic plc.
  - Action: departing
  - Role: Executive Vice President and President, Neuroscience Portfolio
  source text: Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/0001628280-26-035959-index.htm
- Executive change
  Kweli Thompson changed role as Executive Vice President and President, Neuroscience Portfolio at Medtronic plc.
  - Action: assuming the role
  - Role: Executive Vice President and President, Neuroscience Portfolio
  source text: Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/0001628280-26-035959-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.